SCHEMBL8259809

SCHEMBL8259809

COc1ccc(-n2[nH]c(CN3CCN(c4c(Cl)cncc4Cl)CC3)c(Cl)c2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.41
PARP14 Q460N5 1/20 0.41
ALDH1A1 P00352 6/20 0.40
MAPT P10636 6/20 0.40
TDP1 Q9NUW8 2/20 0.40
GLA P06280 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GABRA1 P14867 4/20 0.39
GABRG2 P18507 4/20 0.39
GABRB3 P28472 4/20 0.39
GABRA3 P34903 4/20 0.39
GABRA5 P31644 3/20 0.39
GABRA6 Q16445 3/20 0.39
KMT2A Q03164 4/20 0.39
HTT P42858 2/20 0.39
NPC1 O15118 1/20 0.39
S1PR4 O95977 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329508 0.79 ALDH1A1 (0.41) HSD17B10GAATSHRALDH1A1MAPT
SCHEMBL8258042 0.73 HTR3E (0.48) MAPTKDM4EDRD4
SCHEMBL8255009 0.71 ALDH1A1 (0.47) TSHRALDH1A1MAPTKMT2AHTT
SCHEMBL4318159 0.70 ALDH1A1 (0.48) GAAALDH1A1MAPTKMT2AHTT
SCHEMBL4318732 0.68 LSS (0.39) GAAALDH1A1MAPTMAPK1SMN1; SMN2
SCHEMBL8258746 0.67 ALDH1A1 (0.43) ALDH1A1MAPTKMT2AHTTSMN1; SMN2
SCHEMBL5388551 0.67 PARP1 (0.43) DRD4
SCHEMBL8258604 0.65 MEN1 (0.54) GAATSHRALDH1A1MAPTNPSR1
SCHEMBL4330719 0.64 ALDH1A1 (0.44) ALDH1A1MAPTNPSR1DRD4
SCHEMBL5327466 0.63 PKM (0.59) GAATSHRALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed